Serum galectin-3 levels in patients with nonalcoholic fatty liver disease


YILMAZ Y. , EREN F. , Kurt R., Yonal O., Polat Z., Senates E., ...Daha Fazla

CLINICAL BIOCHEMISTRY, cilt.44, ss.955-958, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Objectives: Galectin-3 might serve as a biomarker of human metabolic alterations. We measured serum levels of galectin-3 in patients with nonalcoholic fatty liver disease (NAFLD) and examined their association with clinical and histological phenotypes.